These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 21403612)

  • 1. Deregulation of hepatocyte nuclear factor 4 (HNF4)as a marker of epithelial tumors progression.
    Lazarevich NL; Shavochkina DA; Fleishman DI; Kustova IF; Morozova OV; Chuchuev ES; Patyutko YI
    Exp Oncol; 2010 Sep; 32(3):167-71. PubMed ID: 21403612
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Hepatocyte nuclear factor 4 (HNF4) in epithelial development and carcinogenesis].
    Lazarevich NL; Al'pern DV
    Mol Biol (Mosk); 2008; 42(5):786-97. PubMed ID: 18988528
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatocyte nuclear factor 4 alpha suppresses the development of hepatocellular carcinoma.
    Ning BF; Ding J; Yin C; Zhong W; Wu K; Zeng X; Yang W; Chen YX; Zhang JP; Zhang X; Wang HY; Xie WF
    Cancer Res; 2010 Oct; 70(19):7640-51. PubMed ID: 20876809
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tissue-specific transcription factors in progression of epithelial tumors.
    Lazarevich NL; Fleishman DI
    Biochemistry (Mosc); 2008 May; 73(5):573-91. PubMed ID: 18605982
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differentiation therapy of hepatocellular carcinoma in mice with recombinant adenovirus carrying hepatocyte nuclear factor-4alpha gene.
    Yin C; Lin Y; Zhang X; Chen YX; Zeng X; Yue HY; Hou JL; Deng X; Zhang JP; Han ZG; Xie WF
    Hepatology; 2008 Nov; 48(5):1528-39. PubMed ID: 18925631
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatitis C virus suppresses Hepatocyte Nuclear Factor 4 alpha, a key regulator of hepatocellular carcinoma.
    Vallianou I; Dafou D; Vassilaki N; Mavromara P; Hadzopoulou-Cladaras M
    Int J Biochem Cell Biol; 2016 Sep; 78():315-326. PubMed ID: 27477312
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gankyrin-mediated dedifferentiation facilitates the tumorigenicity of rat hepatocytes and hepatoma cells.
    Sun W; Ding J; Wu K; Ning BF; Wen W; Sun HY; Han T; Huang L; Dong LW; Yang W; Deng X; Li Z; Wu MC; Feng GS; Xie WF; Wang HY
    Hepatology; 2011 Oct; 54(4):1259-72. PubMed ID: 21735473
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tg737 regulates epithelial-mesenchymal transition and cancer stem cell properties via a negative feedback circuit between Snail and HNF4α during liver stem cell malignant transformation.
    Huang Q; Pu M; Zhao G; Dai B; Bian Z; Tang H; Chen C; Liu W; Qu X; Shen L; Tao K
    Cancer Lett; 2017 Aug; 402():52-60. PubMed ID: 28536011
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apoptosis signal-regulating kinase 1 mediates the inhibitory effect of hepatocyte nuclear factor-4α on hepatocellular carcinoma.
    Jiang CF; Wen LZ; Yin C; Xu WP; Shi B; Zhang X; Xie WF
    Oncotarget; 2016 May; 7(19):27408-21. PubMed ID: 27050273
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatocyte nuclear factor 4α-nuclear factor-κB feedback circuit modulates liver cancer progression.
    Ning BF; Ding J; Liu J; Yin C; Xu WP; Cong WM; Zhang Q; Chen F; Han T; Deng X; Wang PQ; Jiang CF; Zhang JP; Zhang X; Wang HY; Xie WF
    Hepatology; 2014 Nov; 60(5):1607-19. PubMed ID: 24752868
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of a TGF-β1-CD147 self-sustaining network in the differentiation plasticity of hepatocellular carcinoma cells.
    Wu J; Lu M; Li Y; Shang YK; Wang SJ; Meng Y; Wang Z; Li ZS; Chen H; Chen ZN; Bian H
    Oncogene; 2016 Oct; 35(42):5468-5479. PubMed ID: 27041581
    [TBL] [Abstract][Full Text] [Related]  

  • 12. EPS15R, TASP1, and PRPF3 are novel disease candidate genes targeted by HNF4alpha splice variants in hepatocellular carcinomas.
    Niehof M; Borlak J
    Gastroenterology; 2008 Apr; 134(4):1191-202. PubMed ID: 18395097
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of hepatocyte nuclear factor 4alpha in metastatic tumor formation of hepatocellular carcinoma and its close relationship with the mesenchymal-epithelial transition markers.
    Yao D; Peng S; Dai C
    BMC Cancer; 2013 Sep; 13():432. PubMed ID: 24059685
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TGFβ overrides HNF4α tumor suppressing activity through GSK3β inactivation: implication for hepatocellular carcinoma gene therapy.
    Cozzolino AM; Alonzi T; Santangelo L; Mancone C; Conti B; Steindler C; Musone M; Cicchini C; Tripodi M; Marchetti A
    J Hepatol; 2013 Jan; 58(1):65-72. PubMed ID: 22960426
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatocyte nuclear factor 4alpha (nuclear receptor 2A1) is essential for maintenance of hepatic gene expression and lipid homeostasis.
    Hayhurst GP; Lee YH; Lambert G; Ward JM; Gonzalez FJ
    Mol Cell Biol; 2001 Feb; 21(4):1393-403. PubMed ID: 11158324
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression profiling suggested a regulatory role of liver-enriched transcription factors in human hepatocellular carcinoma.
    Xu L; Hui L; Wang S; Gong J; Jin Y; Wang Y; Ji Y; Wu X; Han Z; Hu G
    Cancer Res; 2001 Apr; 61(7):3176-81. PubMed ID: 11306505
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Control of differentiation in progression of epithelial tumors.
    Abelev GI; Lazarevich NL
    Adv Cancer Res; 2006; 95():61-113. PubMed ID: 16860656
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of Hepatocyte Nuclear Factor 4 Alpha in Liver Cancer.
    Kotulkar M; Paine-Cabrera D; Apte U
    Semin Liver Dis; 2024 Aug; 44(3):383-393. PubMed ID: 38901435
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A concerted action of HNF4alpha and HNF1alpha links hepatitis B virus replication to hepatocyte differentiation.
    Quasdorff M; Hösel M; Odenthal M; Zedler U; Bohne F; Gripon P; Dienes HP; Drebber U; Stippel D; Goeser T; Protzer U
    Cell Microbiol; 2008 Jul; 10(7):1478-90. PubMed ID: 18346225
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RASSF1A expression inhibits the growth of hepatocellular carcinoma from Qidong County.
    Xue WJ; Li C; Zhou XJ; Guan HG; Qin L; Li P; Wang ZW; Qian HX
    J Gastroenterol Hepatol; 2008 Sep; 23(9):1448-58. PubMed ID: 17683489
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.